Clinical Trials on Acquired Immune Deficiency Syndrome Virus

Total 11883 results

Cantonal Hospital of St. Gallen

Completed

Nevirapine + 3TC Based Maintenance Therapy for HIV Infection (NVP+3TC)

HIV Infections

Switzerland
Assiut University

Unknown

Prevalence,Knowledge and Attitude of HIV /AIDS in Luxor

HIV/AIDS

Egypt
Impact Research & Development Organization
Centers for Disease Control and Prevention; Kenya Ministry of Health

Completed

Evaluating Demand Creation Strategies for Voluntary Medical Male Circumcision (VMMC) in Kenya (TASCO)

HIV/AIDS

Kenya
Gadjah Mada University
Udayana University; World Health Organization; Kirby Institute; Universitas Padjadjaran and other collaborators

Completed

HIV Awal (Early) Testing & Treatment Indonesia Project Observational Phase

HIV/AIDS
Equip, Lesotho
United States Agency for International Development (USAID); Elizabeth Glaser... and other collaborators

Unknown

Outcomes of Differentiated Models of Antiretroviral Treatment (ART) Provision ([MMD])

HIV/AIDS

Lesotho
Vanderbilt University Medical Center
University of Cape Town

Completed

CareConekta: A Pilot Study of a Smartphone App in South Africa

HIV/AIDS

South Africa
Massachusetts General Hospital
University of British Columbia; Dana-Farber Cancer Institute; University of California... and other collaborators

Completed

International HIV Antiretroviral Adherence, Resistance and Survival (UARTO)

HIV/AIDS

Uganda
Claremont Graduate University
National Institute on Drug Abuse (NIDA)

Completed

Translation of Basic Research in Cognitive Science to HIV Risk

HIV/AIDS
Vanderbilt University Medical Center
National Center for AIDS/STD Control and Prevention, China CDC

Completed

Multi-component HIV Intervention Packages for Chinese Men Who Have Sex With Men -Test, Link and Care (TLC) (MP3)

HIV/AIDS
Boston University
The Brooklyn Hospital Center; Justice Resource Institute; Puerto Rico Community... and other collaborators

Completed

Minority AIDS Initiative Retention and Re-Engagement Project

HIV/AIDS

United States, Puerto Rico
Columbia University

Completed

Pediatric Decentralization of ART in South Africa

HIV/AIDS

South Africa
Centre for the AIDS Programme of Research in South...
MIET Africa; KwaZulu-Natal Department of Education; Embassy of the Kingdom of...

Completed

Reducing HIV in Adolescents (RHIVA)

HIV Infections

South Africa
National Institute of Allergy and Infectious Diseases...
Glaxo Wellcome

Completed

A Treatment IND for Retrovir Brand Zidovudine (AZT) Therapy of Pediatric Patients With HIV Disease

HIV Infections

United States
Alexion

Terminated

Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With HIV Infection and Modestly Detectable Viral Load.

HIV Infections

United States
Columbia University
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Mother Infant Retention for Health: MIR4Health (MIR4HEALTH)

HIV/AIDS

Kenya
Coordinación de Investigación en Salud, Mexico
Instituto Mexicano del Seguro Social

Completed

Effect of Omega 3 Fatty Acids on Oxidative Stress in HIV Seropositive Patients

HIV/AIDS

Mexico
Makerere University
Rakai Health Sciences Program

Unknown

Demand Creation for Couples' HIV Counseling and Testing

HIV/AIDS
Johns Hopkins Bloomberg School of Public Health

Completed

Adapting and Evaluating an EBI to Prevent HIV/AIDS Risk Among Apache Youth

HIV/AIDS

United States
Kristine Patterson, MD
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Sex, Aging and Antiretroviral Pharmacokinetics

HIV Infections

United States
Avexa

Terminated

Study of the Efficacy and Safety of Apricitabine, a New NRTI, to Treat Drug-resistant HIV Infection

HIV Infections

Canada, United States, Australia, United Kingdom, Thailand, Germany, Italy, Israel, Belgium, Puerto Rico, Peru
International Partnership for Microbicides, Inc.

Completed

A Safety and Acceptability Study of a Vaginal Ring Microbicide Delivery Method

HIV Infections

South Africa, Tanzania
Centers for Disease Control and Prevention
University of North Carolina, Chapel Hill; Kamuzu Central Hospital

Completed

Breastfeeding, Antiretroviral, and Nutrition Study

HIV Infections

Malawi
National Institute of Allergy and Infectious Diseases...

Unknown

Resistance to HIV Infection

HIV Infections

United States
Oxo Chemie GmbH

Completed

A Study of WF 10 IV Solution in Patients With Advanced HIV Disease

HIV Infections

United States
Boehringer Ingelheim

Completed

An Open-Label, Non-Randomized Trial to Evaluate the Tolerability and Safety of Viramune (Nevirapine) in Adult and Pediatric Patients With Progressive HIV Disease

HIV Infections

United States
Glaxo Wellcome

Completed

A Study of Retrovir and Epivir Alone or in Combination With 141W94 in HIV-Infected Patients

HIV Infections

United States
Gilead Sciences

Completed

A Compassionate Use Study of Tenofovir Disoproxil Fumarate as Treatment for HIV Infection

HIV Infections

United States
Glaxo Wellcome

Completed

An Oral Dose-Ranging Finding Study in Patients With HIV Disease, CDC Classification Groups IIB, III, and IV-C2

HIV Infections

United States
Glaxo Wellcome

Completed

A Study of 1592U89 in HIV-Infected Children

HIV Infections

United States
Hospices Civils de Lyon

Terminated

Selection of Farnesoid X Receptor (FXR) Ligands on the Reactivation of Latent HIV Proviruses (FXR#2)

Human Immunodeficiency Virus I Infection

France
National Institute of Allergy and Infectious Diseases...
Immuno-US

Completed

A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of a 200-mcg Dose

HIV Infections

United States
Fred Hutchinson Cancer Center
University of Washington

Completed

MMF for HIV Reservoir Reduction

Human Immunodeficiency Virus I Infection

United States
Auritec Pharmaceuticals
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Safety and Pharmacokinetic Study of HIV Prophylaxis Using Antiretroviral Intravaginal Rings in Healthy Women

Human Immunodeficiency Virus (HIV) Prophylaxis

United States
ViiV Healthcare
GlaxoSmithKline

Completed

Study of Combined Oral Contraceptive Effects in Female Subjects

Infection, Human Immunodeficiency Virus
ViiV Healthcare
GlaxoSmithKline

Completed

A Phase 1 Antiretroviral Drug-Drug Interaction Study in Healthy Volunteers (DDI)

Infection, Human Immunodeficiency Virus

United States
ViiV Healthcare
GlaxoSmithKline; Shionogi

Completed

A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects (ING112276)

Infection, Human Immunodeficiency Virus

United States, Spain, France, Germany, Italy, Russian Federation
ViiV Healthcare
GlaxoSmithKline; Shionogi

Completed

Study to Compare the Safety and Anti-HIV Effect of GSK1265744 Versus Placebo in HIV-1 Infected Adults (ITZ112929)

Infection, Human Immunodeficiency Virus

United States
ViiV Healthcare
GlaxoSmithKline

Terminated

Dose-finding Study of GSK2248761 in Antiretroviral Therapy-experienced Subjects With NNRTI-resistant HIV Infection (SONNET)

Infection, Human Immunodeficiency Virus

United States, Canada, Italy, Belgium, Romania
ViiV Healthcare

Completed

A Drug Interaction Study Evaluating GSK2248761 and Raltegravir Pharmacokinetics in Healthy Adult Subjects

Infection, Human Immunodeficiency Virus

United States
ViiV Healthcare
GlaxoSmithKline

Completed

Prospective Epidemiological Study Of The Prevalence Of HLAB*5701 In HIV-1 Infected Patients

Infection, Human Immunodeficiency Virus
ViiV Healthcare
GlaxoSmithKline

Terminated

A Study to Determine the Effect of Multiple Doses of BMS-955176 on the Electrocardiograph of Healthy Subjects

Infection, Human Immunodeficiency Virus

United States
ViiV Healthcare
GlaxoSmithKline

Completed

DDI Study of BMS-663068 With Etravirine (ETR) and/or Darunavir (DVR) + Ritonavir (RTV)

Infection, Human Immunodeficiency Virus
ViiV Healthcare

Completed

Relative Bioavailability Study of a Fixed-dose Combination Dolutegravir/Abacavir/Lamivudine Dispersible Tablet

Infection, Human Immunodeficiency Virus

United States
ViiV Healthcare
GlaxoSmithKline

Completed

Study to Evaluate the Effect of Food on the Pharmacokinetics of BMS-626529

Infection, Human Immunodeficiency Virus

United States
GlaxoSmithKline

Completed

GSK706769/KALETRA Drug-drug Interaction Study

Infection, Human Immunodeficiency Virus

United States
ViiV Healthcare
GlaxoSmithKline

Completed

Absolute Bioavailability of BMS-626529 After Oral and Intravenous Dosing

Infection, Human Immunodeficiency Virus

United Kingdom
ViiV Healthcare
GlaxoSmithKline; Shionogi

Completed

Phase 1, Open Label, Two Arm, Fixed Sequence Study to Evaluate the Effect of Rifampin and Rifabutin on GSK1349572 Pharmacokinetics in Healthy Male and Female Volunteers

Infection, Human Immunodeficiency Virus

United States
ViiV Healthcare
GlaxoSmithKline

Completed

A Phase IV, Open Label, 4-period Cross-over Study to Investigate a Drug Interaction Between Lamivudine and Sorbitol Oral Solutions in Healthy Volunteers

Infection, Human Immunodeficiency Virus

United States
ViiV Healthcare
GlaxoSmithKline; Shionogi

Completed

A Study to Evaluate the Effect of Boceprevir and Telaprevir on Dolutegravir Pharmacokinetics in Healthy Adult Subjects (ING115697).

Infection, Human Immunodeficiency Virus

United States
ViiV Healthcare
GlaxoSmithKline

Completed

A Study to Evaluate the Effect of BMS-955176 on Pharmacokinetics of Dolutegravir and the Effect of Dolutegravir on the Pharmacokinetics of BMS-955176

Infection, Human Immunodeficiency Virus

United States

Clinical Trials on Acquired Immune Deficiency Syndrome Virus

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahrain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations